Percutaneous circulatory support device facilitating reduced hemolysis class

Information

  • Patent Grant
  • 12133976
  • Patent Number
    12,133,976
  • Date Filed
    Tuesday, November 22, 2022
    2 years ago
  • Date Issued
    Tuesday, November 5, 2024
    17 days ago
  • CPC
  • Field of Search
    • CPC
    • F04D13/024
    • F04D13/086
    • F04D13/29
    • F04D13/0467
    • F04D13/048
    • A61M60/82
    • A61M60/419
  • International Classifications
    • A61M60/226
    • A61M60/419
    • A61M60/82
    • F04D13/02
    • Term Extension
      91
Abstract
A percutaneous circulatory support device includes a housing having a proximal end portion and a motor carried by the housing. A driving magnet is operatively coupled to the motor, and a driven magnet is operatively coupled to the driving magnet. The driven magnet includes a frustoconical shape. An impeller is disposed within the housing, and the impeller is operatively coupled to the driven magnet. The motor rotates the impeller, via the driving magnet and the driven magnet, relative to the impeller housing to cause blood to flow through the percutaneous circulatory support device and blood is inhibited from pooling in the proximal end portion of the impeller housing.
Description
TECHNICAL FIELD

The present disclosure relates to percutaneous circulatory support systems. More specifically, the disclosure relates to percutaneous circulatory support devices that facilitate reduced hemolysis and/or related complications.


BACKGROUND

Percutaneous circulatory support devices such as devices can provide transient support for up to approximately several weeks in patients with compromised heart function or cardiac output. Operation of such devices, however, may cause some amount of hemolysis (that is, the rupture or destroying of blood cells) or other complications. Hemolysis can in turn cause thrombi formation or other complications. Accordingly, there is a need for improved devices that facilitate reduced hemolysis and/or related complications.


SUMMARY

In an Example 1, a percutaneous circulatory support device comprises a housing comprising a proximal end portion; a motor carried by the housing; a driving magnet operatively coupled to the motor; a driven magnet operatively coupled to the driving magnet; the driven magnet comprising a frustoconical shape; and an impeller disposed within the housing, the impeller being operatively coupled to the driven magnet.


In an Example 2, the percutaneous circulatory support device of Example 1, further comprising an outlet, and wherein the driven magnet is disposed apart from the outlet to define an inverse frustoconical chamber in the housing.


In an Example 3, the percutaneous circulatory support device of either of Examples 1 or 2, further comprising an impeller shaft being fixed relative to the impeller and the driven magnet.


In an Example 4, the percutaneous circulatory support device of any of Examples 1 to 3, further comprising a bearing disposed between the driving magnet and the driven magnet.


In an Example 5, the percutaneous circulatory support device of any of Examples 1 to 4, wherein the driven magnet tapers radially inwardly proceeding in a proximal direction.


In an Example 6, the percutaneous circulatory support device of any of Examples 1 to 4, wherein the driven magnet tapers radially inwardly proceeding in a distal direction.


In an Example 7, the percutaneous circulatory support device of any of Examples 1 to 6, wherein the housing comprises a plurality of outlet apertures each extending to a proximal end of the driven magnet.


In an Example 8, the percutaneous circulatory support device of any of Examples 1 to 7, wherein a proximal portion of the impeller comprises a flattened shape.


In an Example 9, a percutaneous circulatory support device comprises a housing comprising a proximal end portion, an inlet, and an outlet; a motor carried by the housing; a driving magnet operatively coupled to the motor; a driven magnet operatively coupled to the driving magnet; the driven magnet comprising a frustoconical shape and being disposed apart from the outlet to define an inverse frustoconical chamber in the proximal end portion of the housing; and an impeller disposed within the housing, the impeller being operatively coupled to the driven magnet.


In an Example 10, the percutaneous circulatory support device of Example 9, further comprising an impeller shaft being fixed relative to the impeller and the driven magnet.


In an Example 11, the percutaneous circulatory support device of either of Examples 9 or 10, wherein the driven magnet tapers radially inwardly proceeding in a proximal direction.


In an Example 12, the percutaneous circulatory support device of either of Examples 9 or 10, wherein the driven magnet tapers radially inwardly proceeding in a distal direction.


In an Example 13, the percutaneous circulatory support device of any of Examples 9 to 12, wherein the outlet comprises a plurality of outlet apertures each extending to a proximal end of the driven magnet.


In an Example 14, the percutaneous circulatory support device of any of Examples 9 to 13, wherein a proximal portion of the impeller comprises a flattened shape.


In an Example 15, the percutaneous circulatory support device of any of Examples 9 to 14, wherein the housing comprises a motor housing carrying the motor and an impeller housing carrying the impeller.


In an Example 16, a percutaneous circulatory support device comprises an impeller housing comprising a proximal end portion; a motor housing coupled to the impeller housing; a motor carried by the motor housing; a driving magnet operatively coupled to the motor; a driven magnet operatively coupled to the driving magnet; the driven magnet comprising a frustoconical shape; and an impeller disposed within the impeller housing, the impeller being operatively coupled to the driven magnet; wherein the motor rotates the impeller, via the driving magnet and the driven magnet, relative to the impeller housing to cause blood to flow through the percutaneous circulatory support device and blood is inhibited from pooling in the proximal end portion of the impeller housing.


In an Example 17, the percutaneous circulatory support device of Example 16, further comprising an outlet, and wherein the driven magnet is disposed apart from the outlet to define an inverse frustoconical chamber in the impeller housing.


In an Example 18, the percutaneous circulatory support device of Example 16, further comprising an impeller shaft being fixed relative to the impeller and the driven magnet.


In an Example 19, the percutaneous circulatory support device of Example 16, wherein the driving magnet is disposed within the motor housing and the driven magnet is disposed within the impeller housing.


In an Example 20, the percutaneous circulatory support device of Example 16, further comprising a bearing disposed between the driving magnet and the driven magnet.


In an Example 21, the percutaneous circulatory support device of Example 16, wherein the driven magnet tapers radially inwardly proceeding in a proximal direction.


In an Example 22, the percutaneous circulatory support device of Example 16, wherein the driven magnet tapers radially inwardly proceeding in a distal direction.


In an Example 23, the percutaneous circulatory support device of Example 16, wherein the impeller housing comprises a plurality of outlet apertures each extending to a proximal end of the driven magnet.


In an Example 24, the percutaneous circulatory support device of Example 16, wherein a proximal portion of the impeller comprises a flattened shape.


In an Example 25, a percutaneous circulatory support device comprises an impeller housing comprising a proximal end portion, an inlet, and an outlet; a motor housing coupled to the impeller housing; a motor carried by the motor housing; a driving magnet operatively coupled to the motor; a driven magnet operatively coupled to the driving magnet; the driven magnet comprising a frustoconical shape and being disposed apart from the outlet to define an inverse frustoconical chamber in the proximal end portion of the impeller housing; and an impeller disposed within the impeller housing, the impeller being operatively coupled to the driven magnet; wherein the motor rotates the impeller, via the driving magnet and the driven magnet, relative to the impeller housing to cause blood to flow through the percutaneous circulatory support device and blood is inhibited from pooling in the proximal end portion of the impeller housing.


In an Example 26, the percutaneous circulatory support device of Example 25, further comprising an impeller shaft being fixed relative to the impeller and the driven magnet.


In an Example 27, the percutaneous circulatory support device of Example 25, wherein the driven magnet tapers radially inwardly proceeding in a proximal direction.


In an Example 28, the percutaneous circulatory support device of Example 25, wherein the driven magnet tapers radially inwardly proceeding in a distal direction.


In an Example 29, the percutaneous circulatory support device of Example 25, wherein the outlet comprises a plurality of outlet apertures each extending to a proximal end of the driven magnet.


In an Example 30, the percutaneous circulatory support device of Example 25, wherein a proximal portion of the impeller comprises a flattened shape.


In an Example 31, a method for using a percutaneous circulatory support device comprises positioning the percutaneous circulatory support device at a target location within a patient; rotating an impeller of the percutaneous circulatory support device, via a motor, a driving magnet, and a driven magnet comprising a frustoconical shape, to cause blood to flow through the percutaneous circulatory support device, wherein blood is inhibited from pooling in a proximal end portion of an impeller housing of the percutaneous circulatory support device.


In an Example 32, the method of Example 31, wherein rotating the impeller and rotating the driven magnet comprise rotating the impeller and the driven magnet together relative to the impeller housing.


In an Example 33, the method of Example 31, wherein the driven magnet tapers radially inwardly proceeding in a proximal direction.


In an Example 34, the method of Example 31, wherein the driven magnet tapers radially inwardly proceeding in a proximal direction.


In an Example 35, the method of Example 31, wherein the percutaneous circulatory support device further comprises an outlet, and the outlet comprises a plurality of outlet apertures each extending to a proximal end of the driven magnet.


While multiple embodiments are disclosed, still other embodiments of the present invention will become apparent to those skilled in the art from the following detailed description, which shows and describes illustrative embodiments of the invention. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not restrictive.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a side sectional view of an illustrative mechanical circulatory support device (also referred to herein, interchangeably, as a “blood pump”), in accordance with embodiments of the subject matter disclosed herein.



FIG. 2 is a perspective view of the mechanical circulatory support device of FIG. 1, with housing components of the device shown in phantom lines, in accordance with embodiments of the subject matter disclosed herein.



FIG. 3 is a side sectional view of another illustrative mechanical circulatory support device, in accordance with embodiments of the subject matter disclosed herein.



FIG. 4 is a perspective view of the mechanical circulatory support device of FIG. 3, with housing components of the device shown in phantom lines, in accordance with embodiments of the subject matter disclosed herein.





While the invention is amenable to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and are described in detail below. The intention, however, is not to limit the invention to the particular embodiments described. On the contrary, the invention is intended to cover all modifications, equivalents, and alternatives falling within the scope of the invention as defined by the appended claims.


DETAILED DESCRIPTION


FIG. 1 depicts a partial side sectional view of an illustrative mechanical circulatory support device 100 (also referred to herein, interchangeably, as a “blood pump”) in accordance with embodiments of the subject matter disclosed herein. The device 100 may form part of a percutaneous circulatory support system, together with a guidewire and an introducer sheath (not shown). More specifically, the guidewire and the introducer sheath may facilitate percutaneously delivering the device 100 to a target location within a patient, such as within the patient's heart. Alternatively, the device 100 may be delivered to a different target location within a patient.


With continued reference to FIG. 1 and additional reference to FIG. 2, the device 100 generally includes an impeller housing 102 and a motor housing 104. In some embodiments, the impeller housing 102 and the motor housing 104 may be integrally or monolithically constructed. In other embodiments, the impeller housing 102 and the motor housing 104 may be separate components configured to be removably or permanently coupled.


The impeller housing 102 carries an impeller assembly 106 therein. The impeller assembly 106 includes an impeller shaft 108 (FIG. 1) that is rotatably supported by at least one bearing, such as a bearing 110. The impeller assembly 106 also includes an impeller 112 that rotates relative to the impeller housing 102 to drive blood through the device 100. More specifically, the impeller 112 causes blood to flow from a blood inlet 114 (FIG. 1) formed on the impeller housing 102, through the impeller housing 102, and out of a blood outlet 116 formed on the impeller housing 102. In some embodiments and as illustrated, the impeller shaft 108 and the impeller 112 may be separate components, and in other embodiments the impeller shaft 108 and the impeller 112 may be integrated. In some embodiment and as illustrated, the inlet 114 and/or the outlet 116 may each include multiple apertures. In other embodiments, the inlet 114 and/or the outlet 116 may each include a single aperture. In some embodiments and as illustrated, the inlet 114 may be formed on an end portion of the impeller housing 102 and the outlet 116 may be formed on a side portion of the impeller housing 102. In other embodiments, the inlet 114 and/or the outlet 116 may be formed on other portions of the impeller housing 102. In some embodiments, the impeller housing 102 may couple to a distally extending cannula (not shown), and the cannula may receive and deliver blood to the inlet 114.


With continued reference to FIGS. 1 and 2, the motor housing 104 carries a motor 118, and the motor 118 is configured to rotatably drive the impeller 112 relative to the impeller housing 102. In the illustrated embodiment, the motor 118 rotates a drive shaft 120, which is coupled to a driving magnet 122. Rotation of the driving magnet 122 causes rotation of a driven magnet 124, which is connected to and rotates together with the impeller assembly 106. More specifically, in embodiments incorporating the impeller shaft 108, the impeller shaft 108 and the impeller 112 are configured to rotate with the driven magnet 124. In other embodiments, the motor 118 may couple to the impeller assembly 106 via other components.


In some embodiments, a controller (not shown) may be operably coupled to the motor 118 and configured to control the motor 118. In some embodiments, the controller may be disposed within the motor housing 104. In other embodiments, the controller may be disposed outside of the motor housing 104 (for example, in a catheter handle, an independent housing, etc.). In some embodiments, the controller may include multiple components, one or more of which may be disposed within the motor housing 104. According to embodiments, the controller may be, may include, or may be included in one or more Field Programmable Gate Arrays (FPGAs), one or more Programmable Logic Devices (PLDs), one or more Complex PLDs (CPLDs), one or more custom Application Specific Integrated Circuits (ASICs), one or more dedicated processors (e.g., microprocessors), one or more Central Processing Units (CPUs), software, hardware, firmware, or any combination of these and/or other components. Although the controller is referred to herein in the singular, the controller may be implemented in multiple instances, distributed across multiple computing devices, instantiated within multiple virtual machines, and/or the like. In other embodiments, the motor 118 may be controlled in other manners.


With further reference to FIGS. 1 and 2, the device 100 facilitates reduced device-induced hemolysis compared to conventional devices. More specifically, the driven magnet 124 includes an outer surface 126 that has a frustoconical shape. The frustoconical outer surface 126 is disposed apart from the outlet 116 and thereby defines an inverse frustoconical chamber 128 in a proximal end portion 130 of the impeller housing 102. The chamber 128 is relatively large compared to the small spaces between the driven magnet and the impeller housing in a conventional device. As a result, rotation of the driven magnet 124 inhibits blood from pooling in the inverse frustoconical chamber 128, which reduces hemolysis and/or thrombosis. In some embodiments, the frustoconical outer surface 126 of the driven magnet 124 tapers radially inwardly proceeding in a proximal direction. In other embodiments and as shown elsewhere, the frustoconical outer surface 126 of the driven magnet 124 tapers radially inwardly proceeding in a distal direction.


The device 100 may also include one or more additional features that facilitate reduced device-induced hemolysis compared to conventional devices. For example, the apertures of the outlet 116 may be relatively long compared to those of conventional devices. More specifically, the apertures of the outlet 116 may each extend to a proximal end 132 (FIG. 1) of the driven magnet 124. Such apertures further inhibit blood from pooling in the proximal end portion 130 of the impeller housing 102, which reduces hemolysis and/or thrombosis. As another example, a proximal end portion 134 of the impeller 112 may have a flattened shape, in contrast to lips or peaks of the impellers of conventional devices. Such a shape inhibits blood from forming and pooling in vortices adjacent to the impeller 112.



FIGS. 3 and 4 depict another illustrative mechanical circulatory support device 200 in accordance with embodiments of the subject matter disclosed herein. The device 200 includes the same features and components as the device 100, except that the frustoconical outer surface 226 of the driven magnet 224 tapers radially inwardly proceeding in a distal direction.


Various modifications and additions can be made to the exemplary embodiments discussed without departing from the scope of the present invention. For example, while the embodiments described above refer to particular features, the scope of this invention also includes embodiments having different combinations of features and embodiments that do not include all of the described features. Accordingly, the scope of the present invention is intended to embrace all such alternatives, modifications, and variations as fall within the scope of the claims, together with all equivalents thereof.

Claims
  • 1. A percutaneous circulatory support device, comprising: an impeller housing comprising a proximal end portion;a motor housing coupled to the impeller housing;a motor carried by the motor housing;a driving magnet operatively coupled to the motor;a driven magnet operatively coupled to the driving magnet; the driven magnet comprising a frustoconical shape; wherein a portion of a radially outward facing surface of the driven magnet is tapered; andan impeller disposed within the impeller housing, the impeller being operatively coupled to the driven magnet;wherein the motor rotates the impeller, via the driving magnet and the driven magnet, relative to the impeller housing to cause blood to flow through the percutaneous circulatory support device and blood is inhibited from pooling in the proximal end portion of the impeller housing.
  • 2. The percutaneous circulatory support device of claim 1, further comprising an outlet, and wherein the driven magnet is disposed apart from the outlet to define an inverse frustoconical chamber in the impeller housing.
  • 3. The percutaneous circulatory support device of claim 1, further comprising an impeller shaft being fixed relative to the impeller and the driven magnet.
  • 4. The percutaneous circulatory support device of claim 1, wherein the driving magnet is disposed within the motor housing and the driven magnet is disposed within the impeller housing.
  • 5. The percutaneous circulatory support device of claim 1, further comprising a bearing disposed between the driving magnet and the driven magnet.
  • 6. The percutaneous circulatory support device of claim 1, wherein the driven magnet tapers radially inwardly proceeding in a proximal direction.
  • 7. The percutaneous circulatory support device of claim 1, wherein the driven magnet tapers radially inwardly proceeding in a distal direction.
  • 8. The percutaneous circulatory support device of claim 1, wherein the impeller housing comprises a plurality of outlet apertures each extending to a proximal end of the driven magnet.
  • 9. The percutaneous circulatory support device of claim 1, wherein a proximal portion of the impeller comprises a flattened shape.
  • 10. A percutaneous circulatory support device, comprising: an impeller housing comprising a proximal end portion, an inlet, and an outlet;a motor housing coupled to the impeller housing;a motor carried by the motor housing;a driving magnet operatively coupled to the motor;a driven magnet operatively coupled to the driving magnet; the driven magnet comprising a frustoconical shape; wherein a portion of a radially outward facing surface of the driven magnet is tapered; the driven magnet being disposed apart from the outlet to define an inverse frustoconical chamber in the proximal end portion of the impeller housing; andan impeller disposed within the impeller housing, the impeller being operatively coupled to the driven magnet;wherein the motor rotates the impeller, via the driving magnet and the driven magnet, relative to the impeller housing to cause blood to flow through the percutaneous circulatory support device and blood is inhibited from pooling in the proximal end portion of the impeller housing.
  • 11. The percutaneous circulatory support device of claim 10, further comprising an impeller shaft being fixed relative to the impeller and the driven magnet.
  • 12. The percutaneous circulatory support device of claim 10, wherein the driven magnet tapers radially inwardly proceeding in a proximal direction.
  • 13. The percutaneous circulatory support device of claim 10, wherein the driven magnet tapers radially inwardly proceeding in a distal direction.
  • 14. The percutaneous circulatory support device of claim 10, wherein the outlet comprises a plurality of outlet apertures each extending to a proximal end of the driven magnet.
  • 15. The percutaneous circulatory support device of claim 10, wherein a proximal portion of the impeller comprises a flattened shape.
  • 16. A method for using a percutaneous circulatory support device, comprising: positioning the percutaneous circulatory support device at a target location within a patient;rotating an impeller of the percutaneous circulatory support device, via a motor, a driving magnet, and a driven magnet comprising a frustoconical shape, wherein a portion of radially outward facing surface of the driven magnet is tapered, to cause blood to flow through the percutaneous circulatory support device, wherein blood is inhibited from pooling in a proximal end portion of an impeller housing of the percutaneous circulatory support device.
  • 17. The method of claim 16, wherein rotating the impeller and rotating the driven magnet comprise rotating the impeller and the driven magnet together relative to the impeller housing.
  • 18. The method of claim 16, wherein the driven magnet tapers radially inwardly proceeding in a proximal direction.
  • 19. The method of claim 16, wherein the driven magnet tapers radially inwardly proceeding in a distal direction.
  • 20. The method of claim 16, wherein the percutaneous circulatory support device further comprises an outlet, and the outlet comprises a plurality of outlet apertures each extending to a proximal end of the driven magnet.
CROSS REFERENCE TO RELATED APPLICATION

This application claims priority to Provisional Application No. 63/282,207, filed Nov. 23, 2021, which is herein incorporated by reference in its entirety.

US Referenced Citations (148)
Number Name Date Kind
5021048 Buckholtz Jun 1991 A
5145333 Smith Sep 1992 A
5211546 Isaacson et al. May 1993 A
5527159 Bozeman, Jr. et al. Jun 1996 A
5611679 Ghosh et al. Mar 1997 A
5692882 Bozeman, Jr. et al. Dec 1997 A
5928131 Prem Jul 1999 A
5947703 Nojiri et al. Sep 1999 A
5947892 Benkowski et al. Sep 1999 A
5964694 Siess et al. Oct 1999 A
6056520 Nguyen et al. May 2000 A
6135729 Aber Oct 2000 A
6139487 Siess Oct 2000 A
6176822 Nix et al. Jan 2001 B1
6176848 Rau et al. Jan 2001 B1
6201329 Chen Mar 2001 B1
6227820 Jarvik May 2001 B1
6264635 Wampler et al. Jul 2001 B1
6447266 Antaki et al. Sep 2002 B2
7841976 McBride et al. Nov 2010 B2
7927068 McBride et al. Apr 2011 B2
7972122 Larose et al. Jul 2011 B2
8007254 Larose et al. Aug 2011 B2
8043074 Tada Oct 2011 B2
8376707 McBride et al. Feb 2013 B2
8512012 Akdis et al. Aug 2013 B2
8591393 Walters et al. Nov 2013 B2
8597170 Walters et al. Dec 2013 B2
8684904 Campbell et al. Apr 2014 B2
8721517 Zeng et al. May 2014 B2
8770945 Ozaki et al. Jul 2014 B2
8827661 Mori Sep 2014 B2
8992163 McBride et al. Mar 2015 B2
9067005 Ozaki et al. Jun 2015 B2
9072825 Pfeffer et al. Jul 2015 B2
9091271 Bourque Jul 2015 B2
9138518 Yuen et al. Sep 2015 B2
9162017 Evans et al. Oct 2015 B2
9199020 Siess Dec 2015 B2
9308302 Zeng Apr 2016 B2
9308304 Peters et al. Apr 2016 B2
9314557 Ricci et al. Apr 2016 B2
9327067 Zeng et al. May 2016 B2
9364592 McBride et al. Jun 2016 B2
9364593 McBride et al. Jun 2016 B2
9364594 Nsser et al. Jun 2016 B2
9381288 Schenck et al. Jul 2016 B2
9398743 Fox et al. Jul 2016 B1
9421311 Tanner et al. Aug 2016 B2
9446179 Keenan et al. Sep 2016 B2
9616157 Akdis Apr 2017 B2
9717833 McBride et al. Aug 2017 B2
9737652 LaRose et al. Aug 2017 B2
9770543 Tanner et al. Sep 2017 B2
9872947 Keenan et al. Jan 2018 B2
9895476 Larose et al. Feb 2018 B2
9907890 Muller Mar 2018 B2
9956332 Larose et al. May 2018 B2
9962475 Yuen et al. May 2018 B2
9964115 Scheckel May 2018 B2
10029037 Muller et al. Jul 2018 B2
10039872 Zeng et al. Aug 2018 B2
10071192 Zeng Sep 2018 B2
10086121 Fitzgerald et al. Oct 2018 B2
10105475 Muller Oct 2018 B2
10117980 Keenan et al. Nov 2018 B2
10149932 McBride et al. Dec 2018 B2
10215187 McBride et al. Feb 2019 B2
10232099 Peters et al. Mar 2019 B2
10251985 Larose et al. Apr 2019 B2
10251986 Larose et al. Apr 2019 B2
10478539 Pfeffer et al. Nov 2019 B2
10478540 Scheckel et al. Nov 2019 B2
10525178 Zeng Jan 2020 B2
10576192 Muller et al. Mar 2020 B2
10576193 Tanner et al. Mar 2020 B2
10704553 Janeczek et al. Jul 2020 B2
10709829 Muller Jul 2020 B2
10709830 Tanner et al. Jul 2020 B2
10765789 Zeng et al. Sep 2020 B2
10780208 Siess et al. Sep 2020 B2
10786610 Zeng Sep 2020 B2
10799624 Pfeffer et al. Oct 2020 B2
10842921 Siess et al. Nov 2020 B2
10864308 Muller et al. Dec 2020 B2
10864309 McBride et al. Dec 2020 B2
10874783 Pfeffer et al. Dec 2020 B2
10894115 Pfeffer et al. Jan 2021 B2
10918774 Stanfield et al. Feb 2021 B2
10960116 Yuen et al. Mar 2021 B2
10973967 Nyikos et al. Apr 2021 B2
10980927 Pfeffer et al. Apr 2021 B2
11058865 Fitzgerald et al. Jul 2021 B2
11097092 Siess et al. Aug 2021 B2
11107626 Siess et al. Aug 2021 B2
11123539 Pfeffer et al. Sep 2021 B2
11129978 Pfeffer et al. Sep 2021 B2
11167124 Pfeffer et al. Nov 2021 B2
11219755 Siess et al. Jan 2022 B2
11229786 Zeng et al. Jan 2022 B2
11235138 Gross-Hardt et al. Feb 2022 B2
11253693 Pfeffer et al. Feb 2022 B2
11260213 Zeng et al. Mar 2022 B2
11273301 Pfeffer et al. Mar 2022 B2
11311712 Zeng et al. Apr 2022 B2
11338124 Pfeffer et al. May 2022 B2
11357967 Zeng et al. Jun 2022 B2
11400276 Chopra et al. Aug 2022 B2
11471664 Xu et al. Oct 2022 B2
11497896 Tanner et al. Nov 2022 B2
11517736 Earles et al. Dec 2022 B2
11569015 Mourran et al. Jan 2023 B2
11583659 Pfeffer et al. Feb 2023 B2
11628294 Chopra et al. Apr 2023 B2
11648388 Siess May 2023 B2
11672968 Antaki Jun 2023 B2
11708833 McBride et al. Jul 2023 B2
11754075 Schuelke et al. Sep 2023 B2
11786700 Pfeffer et al. Oct 2023 B2
11813443 Hanson et al. Nov 2023 B2
20030233021 Nose et al. Dec 2003 A1
20060222533 Reeves et al. Oct 2006 A1
20080114339 McBride et al. May 2008 A1
20090060743 McBride et al. Mar 2009 A1
20090093764 Pfeffer et al. Apr 2009 A1
20090171137 Farnan et al. Jul 2009 A1
20110237863 Ricci et al. Sep 2011 A1
20110238172 Akidis Sep 2011 A1
20130338559 Franano et al. Dec 2013 A1
20140005467 Farnan et al. Jan 2014 A1
20140010686 Tanner et al. Jan 2014 A1
20140336446 Rodefield Nov 2014 A1
20160271308 LaRose et al. Sep 2016 A1
20170043074 Siess Feb 2017 A1
20170296725 Peters et al. Oct 2017 A1
20180303990 Siess et al. Oct 2018 A1
20180311423 Zeng et al. Nov 2018 A1
20190275224 Hanson et al. Sep 2019 A1
20200306434 Vancamp et al. Oct 2020 A1
20210015982 Kerkhoffs et al. Jan 2021 A1
20210023282 Siess et al. Jan 2021 A1
20210038785 Siess et al. Feb 2021 A1
20210069393 Schauer et al. Mar 2021 A1
20210106810 Pfeffer et al. Apr 2021 A1
20220134082 Pfeffer et al. May 2022 A1
20220384070 Mourran Dec 2022 A1
20230040593 Liu et al. Feb 2023 A1
20240075275 Earles Mar 2024 A1
Foreign Referenced Citations (9)
Number Date Country
3338002 May 1985 DE
0847767 Feb 2005 EP
2301598 Jul 2017 EP
3352808 Sep 2023 EP
9500185 Jan 1995 WO
0117581 Mar 2001 WO
2018197306 Nov 2018 WO
2019135767 Jul 2019 WO
2021113389 Jun 2021 WO
Non-Patent Literature Citations (3)
Entry
US 9,067,007 B2, 06/2015, Tanner et al. (withdrawn)
International Search Report and Written Opinion for International Application No. PCT/US2022/050053 dated Mar. 6, 2023. (14 pages).
International Search Report and Written Opinion for International Application No. PCT/US2022/050694 dated Apr. 5, 2023. (14 pages).
Related Publications (1)
Number Date Country
20230158286 A1 May 2023 US
Provisional Applications (1)
Number Date Country
63282207 Nov 2021 US